\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ jugular\\ venous\\ distention\\.\ \(0\)\
\-\ lungs\\ clear\\ to\\ auscultation\\.\ \(0\)\
\-\ no\\ pedal\\ edema\\.\ \(0\)\
\-\ elevated\\ brain\\ natriuretic\\ peptide\\ \\(bnp\\)\\ of\\ 1798\\ pg\\/ml\\ \\(normal\\ is\\ 0\\.0\\-100\\.0\\)\\ which\\ has\\ been\\ shown\\ to\\ be\\ elevated\\ in\\ failing\\ and\\ hypertrophied\\ hearts\\ as\\ well\\ as\\ in\\ amyloidosis\\.\ \(0\)\
\-\ igg\\ lambda\\ monoclonal\\ gammopathy\\ with\\ an\\ igg\\ of\\ 1352\\ mg\\/dl\\.\ \(0\)\
\-\ in\\ patients\\ presenting\\ with\\ heart\\ failure\\ and\\ amyloidosis\\ of\\ the\\ heart\\,\\ the\\ average\\ life\\ expectancy\\ is\\ less\\ than\\ one\\ year\\.\\ \\ cardiac\\ transplantation\\ may\\ be\\ considered\\ as\\ a\\ treatment\\ option\\.\ \(0\)\
\-\ dual\\ isotope\\ exercise\\ stress\\ myocardial\\ perfusion\\ scintigraphic\\ images\\ demonstrate\\ reversible\\ perfusion\\ defects\\ in\\ the\\ anterior\\ and\\ inferolateral\\ myocardium\\ consistent\\ with\\ ischemia\\.\\ \\ the\\ left\\ ventricle\\ shows\\ reversible\\ dilatation\\ on\\ the\\ stress\\ images\\.\\ \\ the\\ gated\\ left\\ ventricular\\ ejection\\ fraction\\ on\\ this\\ exam\\ was\\ calculated\\ at\\ 27\\%\\ \\(normal\\ greater\\ than\\ 45\\%\\)\\,\\ and\\ \\ the\\ left\\ ventricle\\ demonstrated\\ global\\ hypokinesis\\.\ \(0\)\
\-\ repeat\\ dual\\ isotope\\ exercise\\ stress\\ myocardial\\ perfusion\\ scintigraphic\\ images\\ obtained\\ two\\ months\\ after\\ the\\ first\\ set\\ do\\ not\\ show\\ any\\ evidence\\ of\\ ischemia\\;\\ however\\,\\ the\\ left\\ ventricular\\ reversible\\ dilatation\\,\\ reduced\\ ejection\\ fraction\\,\\ and\\ global\\ hypokinesis\\ persisted\\.\\ \\ radiotracer\\ uptake\\ around\\ the\\ heart\\ and\\ within\\ the\\ right\\ ventricle\\ is\\ more\\ prominent\\ on\\ this\\ exam\\.\ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ technetium\\-99m\\ pyrophosphate\\ scintigraphic\\ images\\ demonstrate\\ diffuse\\ increased\\ myocardial\\ uptake\\ of\\ tc\\-99m\\ pyrophosphate\\.\\ \\ normal\\ radiotracer\\ uptake\\ is\\ present\\ in\\ the\\ ribs\\,\\ sternum\\,\\ and\\ spine\\.\ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ ecg\\ demonstrates\\ a\\ general\\ low\\ voltage\\ which\\ is\\ consistent\\ with\\ an\\ infiltrative\\ process\\.\ \(0\)\
\-\ cardiac\\ amyloidosis\ \(2\)\
\-\ myocarditis\ \(4\)\
\-\ pericarditis\ \(16\)\
\-\ cardiomyopathy\ \(24\)\
\-\ amyloidosis\ \(26\)\
\-\ radiation\\ therapy\\ \ \(68\)\
\-\ persistent\\ blood\\ pool\\ activity\\ \\(occurs\\ if\\ images\\ are\\ taken\\ too\\ early\\ before\\ complete\\ clearance\\ from\\ the\\ blood\\ takes\\ place\\)\ \(0\)\
\-\ doxorubicin\\ \\(adriamycin\\ therapy\\)\ \(0\)\
\-\ the\\ patient\\ presented\\ with\\ complaints\\ of\\ dyspnea\\.\\ \\ he\\ underwent\\ a\\ stress\\ echo\\ that\\ revealed\\ an\\ ejection\\ fraction\\ of\\ 60\\%\\,\\ asymmetric\\ septal\\ hypertrophy\\,\\ and\\ evidence\\ of\\ ischemic\\ inferior\\ left\\ ventricular\\ dysfunction\\.\\ \\ he\\ underwent\\ a\\ cardiac\\ catheterization\\ which\\ revealed\\ two\\ critical\\ stenoses\\ in\\ the\\ right\\ coronary\\ artery\\ and\\ circumflex\\ artery\\.\\ \\ these\\ stenoses\\ were\\ stented\\.\\ \\ subsequent\\ stress\\ thallium\\ exam\\ demonstrated\\ continued\\ evidence\\ of\\ inferior\\ ischemia\\ with\\ significantly\\ reduced\\ left\\ ventricular\\ dysfunction\\.\\ \\ a\\ second\\ cardiac\\ catheterization\\ revealed\\ only\\ luminal\\ irregularities\\ with\\ both\\ stents\\ patent\\.\\ \\ the\\ stress\\ thallium\\ was\\ repeated\\ and\\ showed\\ no\\ perfusion\\ abnormalities\\;\\ however\\,\\ left\\ ventricular\\ dilatation\\ was\\ observed\\.\\ \\ a\\ stress\\ echo\\ was\\ then\\ performed\\ which\\ showed\\ mild\\ to\\ moderate\\ global\\ dysfunction\\ and\\ possible\\ inferior\\ wall\\ ischemia\\.\\ \\ the\\ patient\\ returned\\ for\\ follow\\ up\\ and\\ complained\\ of\\ an\\ unintentional\\ weight\\ loss\\ of\\ 30\\ pounds\\,\\ a\\ poor\\ appetite\\,\\ loss\\ of\\ taste\\,\\ and\\ impotence\\.\\ \\ his\\ ekg\\ at\\ that\\ time\\ showed\\ a\\ very\\ low\\ voltage\\ consistent\\ with\\ an\\ infiltrative\\ process\\.\\ \\ a\\ buccal\\ mucosa\\ biopsy\\ was\\ performed\\ which\\ was\\ strongly\\ positive\\ for\\ amyloid\\ deposition\\.\\ \\ a\\ technetium\\ pyrophosphate\\ study\\ was\\ ordered\\ which\\ revealed\\ diffuse\\ cardiac\\ uptake\\ which\\ was\\ consistent\\ with\\ amyloidosis\\.\ \(0\)\
\-\ this\\ patient\\ most\\ likely\\ has\\ the\\ primary\\ idiopathic\\ form\\ of\\ amyloidosis\\ \\(al\\)\\ based\\ on\\ the\\ fact\\ that\\ he\\ has\\ an\\ associated\\ igg\\ lambda\\ monoclonal\\ gammopathy\\ \\.\\ \\ cardiac\\ symptoms\\ are\\ most\\ common\\ in\\ the\\ primary\\ and\\ heredofamilial\\ amyloidoses\\.\\ \\ it\\ is\\ rare\\ to\\ get\\ cardiac\\ symptoms\\ in\\ the\\ secondary\\ \\(aa\\)\\ form\\ of\\ the\\ disease\\.\\ \\ the\\ patient\\â\\€\\™s\\ poor\\ ejection\\ fraction\\,\\ thickened\\ ventricular\\ walls\\ on\\ echocardiography\\,\\ and\\ global\\ ventricular\\ hypokinesis\\ are\\ all\\ consistent\\ with\\ cardiac\\ amyloidosis\\.\\ \\ the\\ low\\ voltage\\ qrs\\ complex\\ on\\ his\\ ecg\\ is\\ consistent\\ with\\ the\\ disease\\ as\\ well\\.\\ \\ recent\\ studies\\ have\\ associated\\ an\\ elevated\\ brain\\ natriuretic\\ peptide\\ level\\ \\(bnp\\)\\ with\\ amyloidosis\\.\\ \\ this\\ patient\\â\\€\\™s\\ bnp\\ level\\ was\\ excessively\\ elevated\\ at\\ \\ 1798\\ \\(normal\\ 0\\-100\\)\\.\\ \\ the\\ tc\\ pyp\\ study\\ showed\\ diffuse\\ uptake\\ of\\ tc\\ pyp\\ in\\ the\\ heart\\ which\\ is\\ further\\ evidence\\ supporting\\ amyloidosis\\.\\ \\ one\\ must\\ remember\\ that\\ diffuse\\ uptake\\ of\\ \\ tc\\ pyp\\ in\\ the\\ heart\\ is\\ a\\ nonspecific\\ finding\\ for\\ amyloidosis\\ and\\ may\\ also\\ be\\ seen\\ with\\ myocarditis\\,\\ pericarditis\\,\\ cardiomyopathies\\,\\ radiation\\ therapy\\,\\ persistent\\ blood\\ pooling\\,\\ and\\ doxorubicin\\ therapy\\.\\ \\ the\\ fact\\ that\\ the\\ patient\\â\\€\\™s\\ symptoms\\ fit\\ with\\ a\\ global\\ process\\ and\\ that\\ his\\ buccal\\ mucosa\\ biopsy\\ was\\ positive\\ for\\ amyloid\\ deposition\\ are\\ yet\\ further\\ evidence\\ confirming\\ a\\ diagnosis\\ of\\ amyloidosis\\.\\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ victor\\ wl\\,\\ et\\ al\\.\\ amyloidosis\\ of\\ heart\\ and\\ liver\\:\\ comparison\\ of\\ tc\\-99m\\ pyrophosphate\\ and\\ tc\\-99m\\ methylene\\ diphosphonate\\ for\\ detection\\.\\ \\ radiology\\ 1983\\;\\ 148\\:239\\-242\\.\ \(0\)\
\-\ 2\\.\\ christos\\ s\\,\\ et\\ al\\.\\ \\ amyloidosis\\:\\ review\\ and\\ ct\\ manifestations\\.\\ \\ radiographics\\ 2004\\;\\ 24\\:405\\-416\\.\\ \\ \ \(0\)\
\-\ 3\\.\\ thrall\\ jh\\,\\ ziessman\\ ha\\.\\ \\ nuclear\\ medicine\\:\\ the\\ requisites\\.\\ 2nd\\ ed\\.\\ philadelphia\\,\\ pa\\:\\ mosby\\,\\ inc\\.\\ 2001\\:\\ 105\\-107\\.\ \(0\)\
\-\ 4\\.\\ fauci\\ as\\,\\ et\\ al\\.\\ \\ harrison\\â\\€\\™s\\ principles\\ of\\ internal\\ medicine\\.\\ 14th\\ ed\\.\\ new\\ york\\,\\ ny\\:\\ mcgraw\\-hill\\ companies\\,\\ inc\\.\\ 1998\\:\\ 1856\\-1860\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ amyloidosis\\:\\ 0\\.0844019087077282\ \(0\)\
\-\ global\\:\\ 0\\.034466166310906245\ \(0\)\
\-\ ventricular\\:\\ 0\\.0324370668099717\ \(0\)\
\-\ pyp\\:\\ 0\\.032095334067839196\ \(0\)\
\-\ stress\\:\\ 0\\.031828033437164886\ \(0\)\
\-\ cardiac\\:\\ 0\\.031600357213116215\ \(0\)\
\-\ voltage\\:\\ 0\\.02957173996385881\ \(0\)\
\-\ fraction\\:\\ 0\\.02825138907967236\ \(0\)\
\-\ pyrophosphate\\:\\ 0\\.028014543622539197\ \(0\)\
\-\ hypokinesis\\:\\ 0\\.027048145859878428\ \(0\)\
\-\ ejection\\:\\ 0\\.026977776145364153\ \(0\)\
\-\ bnp\\:\\ 0\\.025571937942008894\ \(0\)\
\-\ uptake\\:\\ 0\\.024720753092433583\ \(0\)\
\-\ perfusion\\:\\ 0\\.02361298400672364\ \(0\)\
\-\ tc\\:\\ 0\\.021780236941420932\ \(0\)\
\-\ heart\\:\\ 0\\.021619512006617287\ \(0\)\
\-\ natriuretic\\:\\ 0\\.02139688937855946\ \(0\)\
\-\ 1798\\:\\ 0\\.02139688937855946\ \(0\)\
\-\ igg\\:\\ 0\\.02137528924077691\ \(0\)\
\-\ reversible\\:\\ 0\\.02084153872794241\ \(0\)\
\-\ scintigraphic\\:\\ 0\\.020095928002289452\ \(0\)\
\-\ thallium\\:\\ 0\\.019714493309239203\ \(0\)\
\-\ ischemia\\:\\ 0\\.019278307463630615\ \(0\)\
\-\ myocardial\\:\\ 0\\.0190485418161786\ \(0\)\
\-\ peptide\\:\\ 0\\.018730354697326184\ \(0\)\
\-\ gammopathy\\:\\ 0\\.018730354697326184\ \(0\)\
\-\ isotope\\:\\ 0\\.01803209723991895\ \(0\)\
\-\ tc\\-99m\\:\\ 0\\.017780434919571014\ \(0\)\
\-\ al\\:\\ 0\\.01758525035473926\ \(0\)\
\-\ lambda\\:\\ 0\\.017047958628005927\ \(0\)\
\-\ myocarditis\\:\\ 0\\.017047958628005927\ \(0\)\
\-\ dysfunction\\:\\ 0\\.016575868496086832\ \(0\)\
\-\ monoclonal\\:\\ 0\\.016063820016092908\ \(0\)\
\-\ buccal\\:\\ 0\\.015808090609156437\ \(0\)\
\-\ which\\:\\ 0\\.015486840652840277\ \(0\)\
\-\ consistent\\:\\ 0\\.015257026229353422\ \(0\)\
\-\ doxorubicin\\:\\ 0\\.01499141042318262\ \(0\)\
\-\ s\\:\\ 0\\.014871163028607932\ \(0\)\
\-\ stenoses\\:\\ 0\\.014667305101278437\ \(0\)\
\-\ pericarditis\\:\\ 0\\.014381423946772654\ \(0\)\
\-\ ecg\\:\\ 0\\.014250192827184606\ \(0\)\
\-\ dual\\:\\ 0\\.01412569453983618\ \(0\)\
\-\ elevated\\:\\ 0\\.014074351268733314\ \(0\)\
\-\ inc\\:\\ 0\\.013683166489365416\ \(0\)\
\-\ showed\\:\\ 0\\.013600986737493671\ \(0\)\
\-\ evidence\\:\\ 0\\.013594918588391248\ \(0\)\
\-\ amyloid\\:\\ 0\\.013397285334859633\ \(0\)\
\-\ dilatation\\:\\ 0\\.013333350107289026\ \(0\)\
\-\ revealed\\:\\ 0\\.013312980047893655\ \(0\)\
\-\ catheterization\\:\\ 0\\.013309014353862362\ \(0\)\
\-\ et\\:\\ 0\\.01273324671161025\ \(0\)\
\-\ diffuse\\:\\ 0\\.012558288448423858\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.012398188056531338\ \(0\)\
\-\ was\\:\\ 0\\.011993659250166102\ \(0\)\
\-\ process\\:\\ 0\\.011978393755466193\ \(0\)\
\-\ infiltrative\\:\\ 0\\.011901687909073668\ \(0\)\
\-\ ventricle\\:\\ 0\\.011659188049436024\ \(0\)\
\-\ deposition\\:\\ 0\\.01158365814595133\ \(0\)\
\-\ therapy\\:\\ 0\\.011090489302138897\ \(0\)\
\-\ \\:\\:\\ 0\\.010973541902821989\ \(0\)\
\-\ mucosa\\:\\ 0\\.010950129443597884\ \(0\)\
\-\ reduced\\:\\ 0\\.01091754929716065\ \(0\)\
\-\ fact\\:\\ 0\\.01091754929716065\ \(0\)\
\-\ echo\\:\\ 0\\.010791433425969603\ \(0\)\
\-\ that\\:\\ 0\\.010747432489505996\ \(0\)\
\-\ 0\\.0\\-100\\.0\\:\\ 0\\.01069844468927973\ \(0\)\
\-\ hearts\\:\\ 0\\.01069844468927973\ \(0\)\
\-\ 1352\\:\\ 0\\.01069844468927973\ \(0\)\
\-\ heredofamilial\\:\\ 0\\.01069844468927973\ \(0\)\
\-\ amyloidoses\\:\\ 0\\.01069844468927973\ \(0\)\
\-\ qrs\\:\\ 0\\.01069844468927973\ \(0\)\
\-\ excessively\\:\\ 0\\.01069844468927973\ \(0\)\
\-\ 0\\-100\\:\\ 0\\.01069844468927973\ \(0\)\
\-\ cardiomyopathies\\:\\ 0\\.01069844468927973\ \(0\)\
\-\ 148\\:239\\-242\\:\\ 0\\.01069844468927973\ \(0\)\
\-\ christos\\:\\ 0\\.01069844468927973\ \(0\)\
\-\ 24\\:405\\-416\\:\\ 0\\.01069844468927973\ \(0\)\
\-\ 105\\-107\\:\\ 0\\.01069844468927973\ \(0\)\
\-\ 1856\\-1860\\:\\ 0\\.01069844468927973\ \(0\)\
\-\ exercise\\:\\ 0\\.010642479672629086\ \(0\)\
\-\ inferior\\:\\ 0\\.010555763451549986\ \(0\)\
\-\ an\\:\\ 0\\.010038415109214938\ \(0\)\
\-\ images\\:\\ 0\\.009946989635615012\ \(0\)\
\-\ victor\\:\\ 0\\.009857246654619602\ \(0\)\
\-\ fauci\\:\\ 0\\.009857246654619602\ \(0\)\
\-\ companies\\:\\ 0\\.009857246654619602\ \(0\)\
\-\ medicine\\:\\ 0\\.009838214779535781\ \(0\)\
\-\ \\;\\:\\ 0\\.009832141691517445\ \(0\)\
\-\ form\\:\\ 0\\.009697176840683157\ \(0\)\
\-\ radiotracer\\:\\ 0\\.009677681278311158\ \(0\)\
\-\ impotence\\:\\ 0\\.009365177348663092\ \(0\)\
\-\ wl\\:\\ 0\\.009365177348663092\ \(0\)\
\-\ poor\\:\\ 0\\.009334235738811886\ \(0\)\
\-\ \\,\\:\\ 0\\.009198885721461221\ \(0\)\
\-\ stented\\:\\ 0\\.009016048619959475\ \(0\)\
\-\ 14th\\:\\ 0\\.009016048619959475\ \(0\)\
\-\ his\\:\\ 0\\.008966828984151451\ \(0\)\
\-\ ed\\:\\ 0\\.008765805186625491\ \(0\)\
\-\ adriamycin\\:\\ 0\\.008745243339238346\ \(0\)\
\-\ methylene\\:\\ 0\\.008745243339238346\ \(0\)\
\-\ harrison\\:\\ 0\\.008745243339238346\ \(0\)\
\-\ he\\:\\ 0\\.008680293720994003\ \(0\)\
\-\ low\\:\\ 0\\.008651097279853397\ \(0\)\
\-\ expectancy\\:\\ 0\\.008523979314002963\ \(0\)\
\-\ 1983\\:\\ 0\\.008523979314002963\ \(0\)\
\-\ blood\\:\\ 0\\.008491787885349392\ \(0\)\
\-\ inferolateral\\:\\ 0\\.008336903246251437\ \(0\)\
\-\ principles\\:\\ 0\\.008336903246251437\ \(0\)\
\-\ persistent\\:\\ 0\\.008272686049772765\ \(0\)\
\-\ pedal\\:\\ 0\\.008174850585299346\ \(0\)\
\-\ failing\\:\\ 0\\.008174850585299346\ \(0\)\
\-\ technetium\\-99m\\:\\ 0\\.008174850585299346\ \(0\)\
\-\ circumflex\\:\\ 0\\.008174850585299346\ \(0\)\
\-\ ziessman\\:\\ 0\\.008174850585299346\ \(0\)\
\-\ ny\\:\\ 0\\.008174850585299346\ \(0\)\
\-\ mcgraw\\-hill\\:\\ 0\\.008174850585299346\ \(0\)\
\-\ left\\:\\ 0\\.008122253501104858\ \(0\)\
\-\ myocardium\\:\\ 0\\.008031910008046454\ \(0\)\
\-\ taste\\:\\ 0\\.008031910008046454\ \(0\)\
\-\ thrall\\:\\ 0\\.008031910008046454\ \(0\)\
\-\ diphosphonate\\:\\ 0\\.007904045304578219\ \(0\)\
\-\ \\(\\:\\ 0\\.007889873223537312\ \(0\)\
\-\ as\\:\\ 0\\.007843310108580873\ \(0\)\
\-\ \\)\\:\\ 0\\.00779349420997542\ \(0\)\
\-\ unintentional\\:\\ 0\\.007788377610640931\ \(0\)\
\-\ symptoms\\:\\ 0\\.007753607318803905\ \(0\)\
\-\ gated\\:\\ 0\\.007682781279342836\ \(0\)\
\-\ pg\\/ml\\:\\ 0\\.007585642071001166\ \(0\)\
\-\ technetium\\:\\ 0\\.007585642071001166\ \(0\)\
\-\ supporting\\:\\ 0\\.007585642071001166\ \(0\)\
\-\ pooling\\:\\ 0\\.007585642071001166\ \(0\)\
\-\ calculated\\:\\ 0\\.00749570521159131\ \(0\)\
\-\ jh\\:\\ 0\\.00749570521159131\ \(0\)\
\-\ stents\\:\\ 0\\.007411975998621708\ \(0\)\
\-\ fit\\:\\ 0\\.007411975998621708\ \(0\)\
\-\ biopsy\\:\\ 0\\.007358478741836797\ \(0\)\
\-\ clearance\\:\\ 0\\.007260078980473643\ \(0\)\
\-\ \\%\\:\\ 0\\.007257236771890805\ \(0\)\
\-\ sternum\\:\\ 0\\.007190711973386327\ \(0\)\
\-\ cardiomyopathy\\:\\ 0\\.007190711973386327\ \(0\)\
\-\ irregularities\\:\\ 0\\.007190711973386327\ \(0\)\
\-\ underwent\\:\\ 0\\.007116980668636454\ \(0\)\
\-\ remember\\:\\ 0\\.007003635905634799\ \(0\)\
\-\ set\\:\\ 0\\.006947179575980803\ \(0\)\
\-\ persisted\\:\\ 0\\.006947179575980803\ \(0\)\
\-\ transplantation\\:\\ 0\\.0068932332621812475\ \(0\)\
\-\ luminal\\:\\ 0\\.0068932332621812475\ \(0\)\
\-\ ha\\:\\ 0\\.0068932332621812475\ \(0\)\
\-\ exam\\:\\ 0\\.006834589587194921\ \(0\)\
\-\ study\\:\\ 0\\.006824347953543589\ \(0\)\
\-\ radiation\\:\\ 0\\.006806435071753243\ \(0\)\
\-\ york\\:\\ 0\\.006792041989196963\ \(0\)\
\-\ positive\\:\\ 0\\.006730304830786691\ \(0\)\
\-\ requisites\\:\\ 0\\.006698642667429817\ \(0\)\
\-\ aa\\:\\ 0\\.006654507176931181\ \(0\)\
\-\ hypertrophied\\:\\ 0\\.006611920623762164\ \(0\)\
\-\ echocardiography\\:\\ 0\\.006611920623762164\ \(0\)\
\-\ 1998\\:\\ 0\\.006611920623762164\ \(0\)\
\-\ further\\:\\ 0\\.006595738208253053\ \(0\)\
\-\ confirming\\:\\ 0\\.00657077796396158\ \(0\)\
\-\ normal\\:\\ 0\\.00650297308057816\ \(0\)\
\-\ critical\\:\\ 0\\.006455110270024293\ \(0\)\
\-\ pounds\\:\\ 0\\.006455110270024293\ \(0\)\
\-\ takes\\:\\ 0\\.0063495139387261985\ \(0\)\
\-\ get\\:\\ 0\\.0063495139387261985\ \(0\)\
\-\ a\\:\\ 0\\.006257035708303175\ \(0\)\
\-\ ekg\\:\\ 0\\.006252374730384529\ \(0\)\
\-\ brain\\:\\ 0\\.006241144474035829\ \(0\)\
\-\ patient\\:\\ 0\\.006237319885313505\ \(0\)\
\-\ artery\\:\\ 0\\.006176043670165531\ \(0\)\
\-\ primary\\:\\ 0\\.006144136560426447\ \(0\)\
\-\ is\\:\\ 0\\.006141525492066178\ \(0\)\
\-\ mosby\\:\\ 0\\.006105981541320676\ \(0\)\
\-\ demonstrated\\:\\ 0\\.006085970831206231\ \(0\)\
\-\ pool\\:\\ 0\\.006078708658005071\ \(0\)\
\-\ appetite\\:\\ 0\\.006078708658005071\ \(0\)\
\-\ radiographics\\:\\ 0\\.006078708658005071\ \(0\)\
\-\ average\\:\\ 0\\.00605203522752112\ \(0\)\
\-\ detection\\:\\ 0\\.006025935463903446\ \(0\)\
\-\ loss\\:\\ 0\\.006020544107933105\ \(0\)\
\-\ repeated\\:\\ 0\\.006000385210022581\ \(0\)\
\-\ level\\:\\ 0\\.005977885989434301\ \(0\)\
\-\ jugular\\:\\ 0\\.005950843954536834\ \(0\)\
\-\ two\\:\\ 0\\.005940124363145644\ \(0\)\
\-\ manifestations\\:\\ 0\\.00590324600168091\ \(0\)\
\-\ has\\:\\ 0\\.0058423542615082934\ \(0\)\
\-\ mg\\/dl\\:\\ 0\\.005835176260599547\ \(0\)\
\-\ coronary\\:\\ 0\\.005835176260599547\ \(0\)\
\-\ too\\:\\ 0\\.0058133091422710535\ \(0\)\
\-\ yet\\:\\ 0\\.0058133091422710535\ \(0\)\
\-\ philadelphia\\:\\ 0\\.0058133091422710535\ \(0\)\
\-\ option\\:\\ 0\\.005791829072975665\ \(0\)\
\-\ performed\\:\\ 0\\.0057829571146294145\ \(0\)\
\-\ however\\:\\ 0\\.005775165183488034\ \(0\)\
\-\ strongly\\:\\ 0\\.005770722589102038\ \(0\)\
\-\ are\\:\\ 0\\.005654727536551464\ \(0\)\
\-\ septal\\:\\ 0\\.005651256481318963\ \(0\)\
\-\ one\\:\\ 0\\.005620707241045252\ \(0\)\
\-\ ribs\\:\\ 0\\.005595662384193607\ \(0\)\
\-\ 2004\\:\\ 0\\.005577682911153387\ \(0\)\
\-\ distention\\:\\ 0\\.005542503861549926\ \(0\)\
\-\ 2001\\:\\ 0\\.005508315904066071\ \(0\)\
\-\ complained\\:\\ 0\\.005475064721798942\ \(0\)\
\-\ than\\:\\ 0\\.005434584599316198\ \(0\)\
\-\ comparison\\:\\ 0\\.0053957167129848015\ \(0\)\
\-\ nuclear\\:\\ 0\\.005350484437745442\ \(0\)\
\-\ hypertrophy\\:\\ 0\\.005335774048749878\ \(0\)\
\-\ nonspecific\\:\\ 0\\.005335774048749878\ \(0\)\
\-\ significantly\\:\\ 0\\.005306877630432259\ \(0\)\
\-\ returned\\:\\ 0\\.005306877630432259\ \(0\)\
\-\ walls\\:\\ 0\\.005292683407418677\ \(0\)\
\-\ auscultation\\:\\ 0\\.005278653283145527\ \(0\)\
\-\ on\\:\\ 0\\.005271051060913311\ \(0\)\
\-\ the\\:\\ 0\\.0052011260021995135\ \(0\)\
\-\ 2nd\\:\\ 0\\.005171895063550919\ \(0\)\
\-\ in\\:\\ 0\\.005114044055100181\ \(0\)\
\-\ patent\\:\\ 0\\.005109645919876706\ \(0\)\
\-\ ischemic\\:\\ 0\\.005050434555593416\ \(0\)\
\-\ place\\:\\ 0\\.005038931225551494\ \(0\)\
\-\ asymmetric\\:\\ 0\\.005038931225551494\ \(0\)\
\-\ observed\\:\\ 0\\.004972111107610926\ \(0\)\
\-\ dyspnea\\:\\ 0\\.0049087788828893605\ \(0\)\
\-\ associated\\:\\ 0\\.004894326606572091\ \(0\)\
\-\ repeat\\:\\ 0\\.004878310532002132\ \(0\)\
\-\ ordered\\:\\ 0\\.004878310532002132\ \(0\)\
\-\ 27\\:\\ 0\\.004810058446658836\ \(0\)\
\-\ be\\:\\ 0\\.004797657973339548\ \(0\)\
\-\ 45\\:\\ 0\\.0047912426862996545\ \(0\)\
\-\ most\\:\\ 0\\.004788434810019602\ \(0\)\
\-\ demonstrate\\:\\ 0\\.004772942090614176\ \(0\)\
\-\ defects\\:\\ 0\\.00476355497056401\ \(0\)\
\-\ idiopathic\\:\\ 0\\.004727594051138802\ \(0\)\
\-\ must\\:\\ 0\\.004727594051138802\ \(0\)\
\-\ well\\:\\ 0\\.004691944060603521\ \(0\)\
\-\ this\\:\\ 0\\.004665714627738509\ \(0\)\
\-\ thickened\\:\\ 0\\.00465037840079874\ \(0\)\
\-\ and\\:\\ 0\\.004587608155796829\ \(0\)\
\-\ may\\:\\ 0\\.004549340701209038\ \(0\)\
\-\ life\\:\\ 0\\.004524177292153051\ \(0\)\
\-\ 60\\:\\ 0\\.004524177292153051\ \(0\)\
\-\ do\\:\\ 0\\.004501908919982909\ \(0\)\
\-\ complaints\\:\\ 0\\.004501908919982909\ \(0\)\
\-\ review\\:\\ 0\\.004494576014089751\ \(0\)\
\-\ continued\\:\\ 0\\.004465679595772131\ \(0\)\
\-\ for\\:\\ 0\\.004424199931084436\ \(0\)\
\-\ before\\:\\ 0\\.004389589068811496\ \(0\)\
\-\ radiology\\:\\ 0\\.0043829025933127454\ \(0\)\
\-\ general\\:\\ 0\\.0043696391582008645\ \(0\)\
\-\ pa\\:\\ 0\\.004337101224401524\ \(0\)\
\-\ taken\\:\\ 0\\.004324326451359063\ \(0\)\
\-\ around\\:\\ 0\\.004317989140702326\ \(0\)\
\-\ references\\:\\ 0\\.0043116847512883645\ \(0\)\
\-\ prominent\\:\\ 0\\.004256372240977298\ \(0\)\
\-\ occurs\\:\\ 0\\.004256372240977298\ \(0\)\
\-\ presenting\\:\\ 0\\.004226698580947972\ \(0\)\
\-\ at\\:\\ 0\\.004215157109823907\ \(0\)\
\-\ considered\\:\\ 0\\.004186337874932823\ \(0\)\
\-\ shown\\:\\ 0\\.004158309094842229\ \(0\)\
\-\ complex\\:\\ 0\\.004152780191279292\ \(0\)\
\-\ 4\\.\\:\\ 0\\.0040831067601951425\ \(0\)\
\-\ moderate\\:\\ 0\\.004077909355107763\ \(0\)\
\-\ failure\\:\\ 0\\.004062449372368163\ \(0\)\
\-\ subsequent\\:\\ 0\\.004037112497342004\ \(0\)\
\-\ rare\\:\\ 0\\.004027124027516136\ \(0\)\
\-\ 30\\:\\ 0\\.0039879724956979066\ \(0\)\
\-\ second\\:\\ 0\\.003983166183542448\ \(0\)\
\-\ based\\:\\ 0\\.003954721313430777\ \(0\)\
\-\ lungs\\:\\ 0\\.003926927910170237\ \(0\)\
\-\ greater\\:\\ 0\\.003895286841833132\ \(0\)\
\-\ activity\\:\\ 0\\.003890833287356236\ \(0\)\
\-\ studies\\:\\ 0\\.003873180725460145\ \(0\)\
\-\ clear\\:\\ 0\\.0038343769577022396\ \(0\)\
\-\ abnormalities\\:\\ 0\\.003809180366138612\ \(0\)\
\-\ early\\:\\ 0\\.0037926686524786864\ \(0\)\
\-\ venous\\:\\ 0\\.0037643029350207875\ \(0\)\
\-\ very\\:\\ 0\\.0037643029350207875\ \(0\)\
\-\ weight\\:\\ 0\\.003717167214976778\ \(0\)\
\-\ then\\:\\ 0\\.003690493784492827\ \(0\)\
\-\ obtained\\:\\ 0\\.0036867307047862155\ \(0\)\
\-\ complete\\:\\ 0\\.003649728075225794\ \(0\)\
\-\ new\\:\\ 0\\.003613820360194852\ \(0\)\
\-\ liver\\:\\ 0\\.003575511542272723\ \(0\)\
\-\ 3\\.\\:\\ 0\\.0035483910341513676\ \(0\)\
\-\ less\\:\\ 0\\.00351206311204209\ \(0\)\
\-\ possible\\:\\ 0\\.003492696867577757\ \(0\)\
\-\ recent\\:\\ 0\\.0034863095252910155\ \(0\)\
\-\ first\\:\\ 0\\.0034799556247401115\ \(0\)\
\-\ internal\\:\\ 0\\.003476791106042198\ \(0\)\
\-\ spine\\:\\ 0\\.0034151742063171695\ \(0\)\
\-\ disease\\:\\ 0\\.0033901396631449126\ \(0\)\
\-\ finding\\:\\ 0\\.0033423076517457295\ \(0\)\
\-\ 2\\.\\:\\ 0\\.0032978691041265266\ \(0\)\
\-\ follow\\:\\ 0\\.0032951449902262546\ \(0\)\
\-\ any\\:\\ 0\\.003265576496446958\ \(0\)\
\-\ 1\\.\\:\\ 0\\.003239307240652428\ \(0\)\
\-\ show\\:\\ 0\\.0031834416680723613\ \(0\)\
\-\ no\\:\\ 0\\.003132685014698308\ \(0\)\
\-\ only\\:\\ 0\\.003118218032141912\ \(0\)\
\-\ wall\\:\\ 0\\.003003833883784886\ \(0\)\
\-\ edema\\:\\ 0\\.002933159574552537\ \(0\)\
\-\ all\\:\\ 0\\.002933159574552537\ \(0\)\
\-\ time\\:\\ 0\\.0029291277029603307\ \(0\)\
\-\ likely\\:\\ 0\\.002925109181960748\ \(0\)\
\-\ secondary\\:\\ 0\\.002899308211782533\ \(0\)\
\-\ shows\\:\\ 0\\.0028511816744282506\ \(0\)\
\-\ months\\:\\ 0\\.002832453027536489\ \(0\)\
\-\ of\\:\\ 0\\.002827762155290981\ \(0\)\
\-\ presented\\:\\ 0\\.0028268903337650593\ \(0\)\
\-\ been\\:\\ 0\\.0028213530211941636\ \(0\)\
\-\ if\\:\\ 0\\.002814009021578441\ \(0\)\
\-\ up\\:\\ 0\\.002788649455162892\ \(0\)\
\-\ mild\\:\\ 0\\.002730890113994098\ \(0\)\
\-\ common\\:\\ 0\\.0027139165193645594\ \(0\)\
\-\ these\\:\\ 0\\.0026988406455799026\ \(0\)\
\-\ patients\\:\\ 0\\.002683949756512167\ \(0\)\
\-\ anterior\\:\\ 0\\.0026708650773819625\ \(0\)\
\-\ both\\:\\ 0\\.0026483009595705356\ \(0\)\
\-\ more\\:\\ 0\\.0025936605695536\ \(0\)\
\-\ increased\\:\\ 0\\.0025369960944170576\ \(0\)\
\-\ diagnosis\\:\\ 0\\.002381334139296626\ \(0\)\
\-\ were\\:\\ 0\\.002354716428021749\ \(0\)\
\-\ present\\:\\ 0\\.0023422436334122336\ \(0\)\
\-\ it\\:\\ 0\\.002331126680258515\ \(0\)\
\-\ \\.\\:\\ 0\\.002283343948008923\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0022653169922975556\ \(0\)\
\-\ have\\:\\ 0\\.002245677279569286\ \(0\)\
\-\ right\\:\\ 0\\.002188426478423341\ \(0\)\
\-\ after\\:\\ 0\\.0021456325274383523\ \(0\)\
\-\ treatment\\:\\ 0\\.0020990497082535036\ \(0\)\
\-\ to\\:\\ 0\\.0020731461574902245\ \(0\)\
\-\ seen\\:\\ 0\\.002049305358091857\ \(0\)\
\-\ also\\:\\ 0\\.002044441254454067\ \(0\)\
\-\ with\\:\\ 0\\.0019879350306534664\ \(0\)\
\-\ within\\:\\ 0\\.001978314816002526\ \(0\)\
\-\ from\\:\\ 0\\.0015369365450900634\ \(0\)\
\-\ not\\:\\ 0\\.0014985663492013777\ \(0\)\
\-\ ct\\:\\ 0\\.0014506112298447121\ \(0\)\
\-\ year\\:\\ 0\\.0011603219287292653\ \(0\)\
